These findings, in addition to the fact that Pten deletion is more common than other PI3K/Akt alterations, suggests that Pten contributes to prostate oncogenesis through multiple mechanisms beyond activation of PI3K/Akt signaling. This evidence concerns the gene AKT1 and male reproductive organ cancer.